{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:11Z","timestamp":1793214611644,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jcjo.2017.11.009","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T12:53:01Z","timestamp":1518526381000},"page":"349-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Methotrexate for the treatment of noninfectious scleritis"],"prefix":"10.1016","volume":"53","author":[{"given":"David S.","family":"Sands","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe C.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2017.11.009_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","article-title":"Visual outcome, treatment results, and prognostic factors in patients with scleritis","volume":"120","author":"Wieringa","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.11.009_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajo.2007.11.010","article-title":"Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis","volume":"145","author":"Jachens","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.11.009_bib3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.survophthal.2016.06.002","article-title":"Treatment and management of scleral disorders","volume":"61","author":"Diaz","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.11.009_bib4","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ophtha.2011.02.043","article-title":"Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis","volume":"118","author":"Sohn","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.11.009_bib5","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.11.009_bib6","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.11.009_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1076\/ocii.11.2.131.15919","article-title":"Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis","volume":"11","author":"Kaplan-Messas","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jcjo.2017.11.009_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40123-016-0067-1","article-title":"Uveitis specialists and rheumatologists select different therapies for idiopathic non-necrotizing anterior scleritis","volume":"5","author":"Ozzello","year":"2016","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jcjo.2017.11.009_bib9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0161-6420(92)31790-7","article-title":"Low-dose methotrexate therapy for ocular inflammatory disease","volume":"99","author":"Shah","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.11.009_bib10","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ophtha.2010.08.027","article-title":"A standardized grading system for scleritis","volume":"118","author":"Sen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.11.009_bib11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ophtha.2004.12.034","article-title":"Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series","volume":"112","author":"Nussenblatt","year":"2005","journal-title":"Ophthalmology"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000841821731061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000841821731061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:07:33Z","timestamp":1757794053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000841821731061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S000841821731061X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2017.11.009","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate for the treatment of noninfectious scleritis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}